Citation Impact
Citing Papers
Conflict of Interest in Medical Research, Education, and Practice
2009 Standout
Management of sexual dysfunction due to antipsychotic drug therapy
2012
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials
2001 Standout
Cognition and Depression: Current Status and Future Directions
2010 Standout
Cognitive Function Across Manic or Hypomanic, Depressed, and Euthymic States in Bipolar Disorder
2004 Standout
Depression
2018 Standout
Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use
2002
Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
2011 Standout
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
2015
Glutamate receptor ion channels
2005 Standout
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Factor structure of hypomania: interrelationships with cyclothymia and the soft bipolar spectrum
2002
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Diagnostic issues in bipolar disorder
2003
Risperidone versus haloperidol: I. meta-analysis of efficacy and safety
1998
Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics
2006
Descending control of pain
2002 Standout
Sunlight and Vitamin D
2013 Standout
Antipsychotic agents in the treatment of bipolar mania
2009
Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey Replication
2007 Standout
Updating P300: An integrative theory of P3a and P3b
2007 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Sarcosine or D-Serine Add-on Treatment for Acute Exacerbation of Schizophrenia
2005
A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia
2008
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
2012
Seasonality of births in schizophrenia and bipolar disorder: a review of the literature
1997
Glutamatergic dysfunction in schizophrenia: From basic neuroscience to clinical psychopharmacology
2008
The HCL-32: Towards a self-assessment tool for hypomanic symptoms in outpatients
2005 Standout
Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
2005 Standout
Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling Pathway
2017
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia
2006
Older age, traumatic brain injury, and cognitive slowing: Some convergent and divergent findings.
2002
The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues
2002
A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation
2004 Standout
Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania
2002
Weight gain in bipolar disorder: pharmacological treatment as a contributing factor
2008
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Toward the future of psychiatric diagnosis: the seven pillars of RDoC
2013 Standout
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
1999 Standout
Comment caractériser et traiter les plaintes de sommeil dans les troubles bipolaires ?
2016
A study on nitric oxide, β-adrenergic receptors and antioxidant status in the polymorphonuclear leukocytes from the patients of depression
2002
Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders
2012
Reconsidering anhedonia in depression: Lessons from translational neuroscience
2010
Interpretation revealed in the blink of an eye: Depressive bias in the resolution of ambiguity.
2002
A Systematic Review of Mortality in Schizophrenia
2007 Standout
A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness
2010 Standout
The new and evolving pharmacotherapy of schizophrenia
2003
An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia
2004
IN VITRO EFFECTS OF ANTIPSYCHOTICS ON HUMAN PLATELET ADHESION AND AGGREGATION AND PLASMA COAGULATION
2007 StandoutNobel
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis
2003
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
2003
Industry sponsorship and research outcome
2012 Standout
Suicide and schizophrenia
2001
Antipsychotics in Adults With Schizophrenia: Comparative Effectiveness of First-Generation Versus Second-Generation Medications
2012
The Impact of Mental Illness Stigma on Seeking and Participating in Mental Health Care
2014 Standout
Risperidone versus typical antipsychotic medication for schizophrenia
2003
Neuroanatomical studies on bipolar disorder
2001
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Cognitive Vulnerability to Emotional Disorders
2004 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study
2003 Standout
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia
2005
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
2019 Standout
Risperidone versus other atypical antipsychotics for schizophrenia
2011
Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents
2000
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
2008 Standout
The evolving epidemiology of bipolar disorder.
2002
Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment
2006
Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses
2001 Standout
Industry sponsorship and research outcome
2017 Standout
Understanding antipsychotic “atypicality”: a clinical and pharmacological moving target
2003
Risperidone in the treatment of schizophrenia: a meta-analysis of randomized controlled trials
1997
Works of J.-M. Azorin being referenced
Valproate for the treatment of acute bipolar depression: Systematic review and meta-analysis
2009
[Frequency and clinical aspects of bipolar II disorder in a French multicenter study: EPIDEP].
2001
Plasma 3‐methoxy‐4‐hydroxyphenylglycol in manic patients: relationships with clinical variables
1990
Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: Results from post hoc analyses
2012
Stimulus preprocessing and response selection in depression: A reaction time study
1995
Early decrease in density of mononuclear leukocyte β-adrenoceptors in depressed patients following amineptine treatment: Possible relation to clinical efficiency
1991
A Double-Blind Comparative Study of Clozapine and Risperidone in the Management of Severe Chronic Schizophrenia
2001
Possible involvement of the dopamine D3 receptor locus in subtypes of bipolar affective disorder
2000
Outcomes for Latin American Versus White Patients Suffering From Acute Mania in a Randomized, Double-Blind Trial Comparing Olanzapine and Haloperidol
2007
Thérapie interpersonnelle et aménagement des rythmes sociaux (TIPARS) : du concept anglo-saxon à l’expérience française
2010
Clozapine in the Treatment of Psychotic Refractory Depression
1993
A 12-Week, Double-blind Comparison of Olanzapine vs Haloperidol in the Treatment of Acute Mania
2003
Antipsychotic and Anxiolytic Properties of Risperidone, Haloperidol, and Methotrimeprazine in Schizophrenic Patients
1996
Season of birth and schizophrenia: Sex difference
1996